The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lung Cancer Diagnostics Kit Market Research Report 2024
Synopsis
The global Lung Cancer Diagnostics Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lung Cancer Diagnostics Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lung Cancer Diagnostics Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lung Cancer Diagnostics Kit include Swift Biosciences, Jiangsu MicroDiag Biomedicine Technology Co., Ltd, Genetic Biotek, Asuragen, Fujirebio, IDL Biotech, LCM Genect srl, Panagene Inc. and ViennaLab Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostics Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostics Kit.
Report Scope
The Lung Cancer Diagnostics Kit market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Diagnostics Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Cancer Diagnostics Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Swift Biosciences
Jiangsu MicroDiag Biomedicine Technology Co., Ltd
Genetic Biotek
Asuragen
Fujirebio
IDL Biotech
LCM Genect srl
Panagene Inc.
ViennaLab Diagnostics
Xian Tianlong Science and Technology Co.,Ltd
Jiangsu Mole Bioscience
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Gencurix
HTG Molecular
Beijing ACCB Biotech Ltd.
Segment by Type
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Segment by Application
Hospitals
Cancer Research Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lung Cancer Diagnostics Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lung Cancer Diagnostics Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Lung Cancer Diagnostics Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lung Cancer Diagnostics Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lung Cancer Diagnostics Kit is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lung Cancer Diagnostics Kit include Swift Biosciences, Jiangsu MicroDiag Biomedicine Technology Co., Ltd, Genetic Biotek, Asuragen, Fujirebio, IDL Biotech, LCM Genect srl, Panagene Inc. and ViennaLab Diagnostics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Diagnostics Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Diagnostics Kit.
Report Scope
The Lung Cancer Diagnostics Kit market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lung Cancer Diagnostics Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Cancer Diagnostics Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Swift Biosciences
Jiangsu MicroDiag Biomedicine Technology Co., Ltd
Genetic Biotek
Asuragen
Fujirebio
IDL Biotech
LCM Genect srl
Panagene Inc.
ViennaLab Diagnostics
Xian Tianlong Science and Technology Co.,Ltd
Jiangsu Mole Bioscience
Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
Gencurix
HTG Molecular
Beijing ACCB Biotech Ltd.
Segment by Type
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Segment by Application
Hospitals
Cancer Research Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lung Cancer Diagnostics Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lung Cancer Diagnostics Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lung Cancer Diagnostics Kit Market Overview
1.1 Product Overview and Scope of Lung Cancer Diagnostics Kit
1.2 Lung Cancer Diagnostics Kit Segment by Type
1.2.1 Global Lung Cancer Diagnostics Kit Market Value Comparison by Type (2024-2030)
1.2.2 Non-Small Cell Lung Cancer
1.2.3 Small Cell Lung Cancer
1.3 Lung Cancer Diagnostics Kit Segment by Application
1.3.1 Global Lung Cancer Diagnostics Kit Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.4 Global Lung Cancer Diagnostics Kit Market Size Estimates and Forecasts
1.4.1 Global Lung Cancer Diagnostics Kit Revenue 2019-2030
1.4.2 Global Lung Cancer Diagnostics Kit Sales 2019-2030
1.4.3 Global Lung Cancer Diagnostics Kit Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lung Cancer Diagnostics Kit Market Competition by Manufacturers
2.1 Global Lung Cancer Diagnostics Kit Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lung Cancer Diagnostics Kit Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lung Cancer Diagnostics Kit Average Price by Manufacturers (2019-2024)
2.4 Global Lung Cancer Diagnostics Kit Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lung Cancer Diagnostics Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lung Cancer Diagnostics Kit, Product Type & Application
2.7 Lung Cancer Diagnostics Kit Market Competitive Situation and Trends
2.7.1 Lung Cancer Diagnostics Kit Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lung Cancer Diagnostics Kit Players Market Share by Revenue
2.7.3 Global Lung Cancer Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lung Cancer Diagnostics Kit Retrospective Market Scenario by Region
3.1 Global Lung Cancer Diagnostics Kit Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lung Cancer Diagnostics Kit Global Lung Cancer Diagnostics Kit Sales by Region: 2019-2030
3.2.1 Global Lung Cancer Diagnostics Kit Sales by Region: 2019-2024
3.2.2 Global Lung Cancer Diagnostics Kit Sales by Region: 2025-2030
3.3 Global Lung Cancer Diagnostics Kit Global Lung Cancer Diagnostics Kit Revenue by Region: 2019-2030
3.3.1 Global Lung Cancer Diagnostics Kit Revenue by Region: 2019-2024
3.3.2 Global Lung Cancer Diagnostics Kit Revenue by Region: 2025-2030
3.4 North America Lung Cancer Diagnostics Kit Market Facts & Figures by Country
3.4.1 North America Lung Cancer Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lung Cancer Diagnostics Kit Sales by Country (2019-2030)
3.4.3 North America Lung Cancer Diagnostics Kit Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lung Cancer Diagnostics Kit Market Facts & Figures by Country
3.5.1 Europe Lung Cancer Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lung Cancer Diagnostics Kit Sales by Country (2019-2030)
3.5.3 Europe Lung Cancer Diagnostics Kit Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lung Cancer Diagnostics Kit Market Facts & Figures by Country
3.6.1 Asia Pacific Lung Cancer Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lung Cancer Diagnostics Kit Sales by Country (2019-2030)
3.6.3 Asia Pacific Lung Cancer Diagnostics Kit Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lung Cancer Diagnostics Kit Market Facts & Figures by Country
3.7.1 Latin America Lung Cancer Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lung Cancer Diagnostics Kit Sales by Country (2019-2030)
3.7.3 Latin America Lung Cancer Diagnostics Kit Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lung Cancer Diagnostics Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Lung Cancer Diagnostics Kit Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lung Cancer Diagnostics Kit Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lung Cancer Diagnostics Kit Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lung Cancer Diagnostics Kit Sales by Type (2019-2030)
4.1.1 Global Lung Cancer Diagnostics Kit Sales by Type (2019-2024)
4.1.2 Global Lung Cancer Diagnostics Kit Sales by Type (2025-2030)
4.1.3 Global Lung Cancer Diagnostics Kit Sales Market Share by Type (2019-2030)
4.2 Global Lung Cancer Diagnostics Kit Revenue by Type (2019-2030)
4.2.1 Global Lung Cancer Diagnostics Kit Revenue by Type (2019-2024)
4.2.2 Global Lung Cancer Diagnostics Kit Revenue by Type (2025-2030)
4.2.3 Global Lung Cancer Diagnostics Kit Revenue Market Share by Type (2019-2030)
4.3 Global Lung Cancer Diagnostics Kit Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lung Cancer Diagnostics Kit Sales by Application (2019-2030)
5.1.1 Global Lung Cancer Diagnostics Kit Sales by Application (2019-2024)
5.1.2 Global Lung Cancer Diagnostics Kit Sales by Application (2025-2030)
5.1.3 Global Lung Cancer Diagnostics Kit Sales Market Share by Application (2019-2030)
5.2 Global Lung Cancer Diagnostics Kit Revenue by Application (2019-2030)
5.2.1 Global Lung Cancer Diagnostics Kit Revenue by Application (2019-2024)
5.2.2 Global Lung Cancer Diagnostics Kit Revenue by Application (2025-2030)
5.2.3 Global Lung Cancer Diagnostics Kit Revenue Market Share by Application (2019-2030)
5.3 Global Lung Cancer Diagnostics Kit Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Swift Biosciences
6.1.1 Swift Biosciences Corporation Information
6.1.2 Swift Biosciences Description and Business Overview
6.1.3 Swift Biosciences Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Swift Biosciences Lung Cancer Diagnostics Kit Product Portfolio
6.1.5 Swift Biosciences Recent Developments/Updates
6.2 Jiangsu MicroDiag Biomedicine Technology Co., Ltd
6.2.1 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Corporation Information
6.2.2 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Description and Business Overview
6.2.3 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Product Portfolio
6.2.5 Jiangsu MicroDiag Biomedicine Technology Co., Ltd Recent Developments/Updates
6.3 Genetic Biotek
6.3.1 Genetic Biotek Corporation Information
6.3.2 Genetic Biotek Description and Business Overview
6.3.3 Genetic Biotek Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Genetic Biotek Lung Cancer Diagnostics Kit Product Portfolio
6.3.5 Genetic Biotek Recent Developments/Updates
6.4 Asuragen
6.4.1 Asuragen Corporation Information
6.4.2 Asuragen Description and Business Overview
6.4.3 Asuragen Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Asuragen Lung Cancer Diagnostics Kit Product Portfolio
6.4.5 Asuragen Recent Developments/Updates
6.5 Fujirebio
6.5.1 Fujirebio Corporation Information
6.5.2 Fujirebio Description and Business Overview
6.5.3 Fujirebio Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Fujirebio Lung Cancer Diagnostics Kit Product Portfolio
6.5.5 Fujirebio Recent Developments/Updates
6.6 IDL Biotech
6.6.1 IDL Biotech Corporation Information
6.6.2 IDL Biotech Description and Business Overview
6.6.3 IDL Biotech Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.6.4 IDL Biotech Lung Cancer Diagnostics Kit Product Portfolio
6.6.5 IDL Biotech Recent Developments/Updates
6.7 LCM Genect srl
6.6.1 LCM Genect srl Corporation Information
6.6.2 LCM Genect srl Description and Business Overview
6.6.3 LCM Genect srl Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LCM Genect srl Lung Cancer Diagnostics Kit Product Portfolio
6.7.5 LCM Genect srl Recent Developments/Updates
6.8 Panagene Inc.
6.8.1 Panagene Inc. Corporation Information
6.8.2 Panagene Inc. Description and Business Overview
6.8.3 Panagene Inc. Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Panagene Inc. Lung Cancer Diagnostics Kit Product Portfolio
6.8.5 Panagene Inc. Recent Developments/Updates
6.9 ViennaLab Diagnostics
6.9.1 ViennaLab Diagnostics Corporation Information
6.9.2 ViennaLab Diagnostics Description and Business Overview
6.9.3 ViennaLab Diagnostics Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ViennaLab Diagnostics Lung Cancer Diagnostics Kit Product Portfolio
6.9.5 ViennaLab Diagnostics Recent Developments/Updates
6.10 Xian Tianlong Science and Technology Co.,Ltd
6.10.1 Xian Tianlong Science and Technology Co.,Ltd Corporation Information
6.10.2 Xian Tianlong Science and Technology Co.,Ltd Description and Business Overview
6.10.3 Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Product Portfolio
6.10.5 Xian Tianlong Science and Technology Co.,Ltd Recent Developments/Updates
6.11 Jiangsu Mole Bioscience
6.11.1 Jiangsu Mole Bioscience Corporation Information
6.11.2 Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Description and Business Overview
6.11.3 Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Product Portfolio
6.11.5 Jiangsu Mole Bioscience Recent Developments/Updates
6.12 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
6.12.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Corporation Information
6.12.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Description and Business Overview
6.12.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Product Portfolio
6.12.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments/Updates
6.13 Gencurix
6.13.1 Gencurix Corporation Information
6.13.2 Gencurix Lung Cancer Diagnostics Kit Description and Business Overview
6.13.3 Gencurix Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Gencurix Lung Cancer Diagnostics Kit Product Portfolio
6.13.5 Gencurix Recent Developments/Updates
6.14 HTG Molecular
6.14.1 HTG Molecular Corporation Information
6.14.2 HTG Molecular Lung Cancer Diagnostics Kit Description and Business Overview
6.14.3 HTG Molecular Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HTG Molecular Lung Cancer Diagnostics Kit Product Portfolio
6.14.5 HTG Molecular Recent Developments/Updates
6.15 Beijing ACCB Biotech Ltd.
6.15.1 Beijing ACCB Biotech Ltd. Corporation Information
6.15.2 Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Description and Business Overview
6.15.3 Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Product Portfolio
6.15.5 Beijing ACCB Biotech Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lung Cancer Diagnostics Kit Industry Chain Analysis
7.2 Lung Cancer Diagnostics Kit Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lung Cancer Diagnostics Kit Production Mode & Process
7.4 Lung Cancer Diagnostics Kit Sales and Marketing
7.4.1 Lung Cancer Diagnostics Kit Sales Channels
7.4.2 Lung Cancer Diagnostics Kit Distributors
7.5 Lung Cancer Diagnostics Kit Customers
8 Lung Cancer Diagnostics Kit Market Dynamics
8.1 Lung Cancer Diagnostics Kit Industry Trends
8.2 Lung Cancer Diagnostics Kit Market Drivers
8.3 Lung Cancer Diagnostics Kit Market Challenges
8.4 Lung Cancer Diagnostics Kit Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Lung Cancer Diagnostics Kit Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Lung Cancer Diagnostics Kit Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Lung Cancer Diagnostics Kit Market Competitive Situation by Manufacturers in 2023
Table 4. Global Lung Cancer Diagnostics Kit Sales (Tons) of Key Manufacturers (2019-2024)
Table 5. Global Lung Cancer Diagnostics Kit Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Diagnostics Kit Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Diagnostics Kit Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Lung Cancer Diagnostics Kit Average Price (US$/Ton) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Lung Cancer Diagnostics Kit, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Lung Cancer Diagnostics Kit, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lung Cancer Diagnostics Kit, Product Type & Application
Table 12. Global Key Manufacturers of Lung Cancer Diagnostics Kit, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lung Cancer Diagnostics Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostics Kit as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lung Cancer Diagnostics Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Lung Cancer Diagnostics Kit Sales by Region (2019-2024) & (Tons)
Table 18. Global Lung Cancer Diagnostics Kit Sales Market Share by Region (2019-2024)
Table 19. Global Lung Cancer Diagnostics Kit Sales by Region (2025-2030) & (Tons)
Table 20. Global Lung Cancer Diagnostics Kit Sales Market Share by Region (2025-2030)
Table 21. Global Lung Cancer Diagnostics Kit Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Lung Cancer Diagnostics Kit Revenue Market Share by Region (2019-2024)
Table 23. Global Lung Cancer Diagnostics Kit Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Lung Cancer Diagnostics Kit Revenue Market Share by Region (2025-2030)
Table 25. North America Lung Cancer Diagnostics Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Lung Cancer Diagnostics Kit Sales by Country (2019-2024) & (Tons)
Table 27. North America Lung Cancer Diagnostics Kit Sales by Country (2025-2030) & (Tons)
Table 28. North America Lung Cancer Diagnostics Kit Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Lung Cancer Diagnostics Kit Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Lung Cancer Diagnostics Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Lung Cancer Diagnostics Kit Sales by Country (2019-2024) & (Tons)
Table 32. Europe Lung Cancer Diagnostics Kit Sales by Country (2025-2030) & (Tons)
Table 33. Europe Lung Cancer Diagnostics Kit Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Lung Cancer Diagnostics Kit Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Lung Cancer Diagnostics Kit Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Lung Cancer Diagnostics Kit Sales by Region (2019-2024) & (Tons)
Table 37. Asia Pacific Lung Cancer Diagnostics Kit Sales by Region (2025-2030) & (Tons)
Table 38. Asia Pacific Lung Cancer Diagnostics Kit Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Lung Cancer Diagnostics Kit Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Lung Cancer Diagnostics Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Lung Cancer Diagnostics Kit Sales by Country (2019-2024) & (Tons)
Table 42. Latin America Lung Cancer Diagnostics Kit Sales by Country (2025-2030) & (Tons)
Table 43. Latin America Lung Cancer Diagnostics Kit Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Lung Cancer Diagnostics Kit Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Lung Cancer Diagnostics Kit Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Lung Cancer Diagnostics Kit Sales by Country (2019-2024) & (Tons)
Table 47. Middle East & Africa Lung Cancer Diagnostics Kit Sales by Country (2025-2030) & (Tons)
Table 48. Middle East & Africa Lung Cancer Diagnostics Kit Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Lung Cancer Diagnostics Kit Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Lung Cancer Diagnostics Kit Sales (Tons) by Type (2019-2024)
Table 51. Global Lung Cancer Diagnostics Kit Sales (Tons) by Type (2025-2030)
Table 52. Global Lung Cancer Diagnostics Kit Sales Market Share by Type (2019-2024)
Table 53. Global Lung Cancer Diagnostics Kit Sales Market Share by Type (2025-2030)
Table 54. Global Lung Cancer Diagnostics Kit Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Lung Cancer Diagnostics Kit Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Lung Cancer Diagnostics Kit Revenue Market Share by Type (2019-2024)
Table 57. Global Lung Cancer Diagnostics Kit Revenue Market Share by Type (2025-2030)
Table 58. Global Lung Cancer Diagnostics Kit Price (US$/Ton) by Type (2019-2024)
Table 59. Global Lung Cancer Diagnostics Kit Price (US$/Ton) by Type (2025-2030)
Table 60. Global Lung Cancer Diagnostics Kit Sales (Tons) by Application (2019-2024)
Table 61. Global Lung Cancer Diagnostics Kit Sales (Tons) by Application (2025-2030)
Table 62. Global Lung Cancer Diagnostics Kit Sales Market Share by Application (2019-2024)
Table 63. Global Lung Cancer Diagnostics Kit Sales Market Share by Application (2025-2030)
Table 64. Global Lung Cancer Diagnostics Kit Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Lung Cancer Diagnostics Kit Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Lung Cancer Diagnostics Kit Revenue Market Share by Application (2019-2024)
Table 67. Global Lung Cancer Diagnostics Kit Revenue Market Share by Application (2025-2030)
Table 68. Global Lung Cancer Diagnostics Kit Price (US$/Ton) by Application (2019-2024)
Table 69. Global Lung Cancer Diagnostics Kit Price (US$/Ton) by Application (2025-2030)
Table 70. Swift Biosciences Corporation Information
Table 71. Swift Biosciences Description and Business Overview
Table 72. Swift Biosciences Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 73. Swift Biosciences Lung Cancer Diagnostics Kit Product
Table 74. Swift Biosciences Recent Developments/Updates
Table 75. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Corporation Information
Table 76. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Description and Business Overview
Table 77. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Lung Cancer Diagnostics Kit Product
Table 79. Jiangsu MicroDiag Biomedicine Technology Co., Ltd Recent Developments/Updates
Table 80. Genetic Biotek Corporation Information
Table 81. Genetic Biotek Description and Business Overview
Table 82. Genetic Biotek Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Genetic Biotek Lung Cancer Diagnostics Kit Product
Table 84. Genetic Biotek Recent Developments/Updates
Table 85. Asuragen Corporation Information
Table 86. Asuragen Description and Business Overview
Table 87. Asuragen Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Asuragen Lung Cancer Diagnostics Kit Product
Table 89. Asuragen Recent Developments/Updates
Table 90. Fujirebio Corporation Information
Table 91. Fujirebio Description and Business Overview
Table 92. Fujirebio Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Fujirebio Lung Cancer Diagnostics Kit Product
Table 94. Fujirebio Recent Developments/Updates
Table 95. IDL Biotech Corporation Information
Table 96. IDL Biotech Description and Business Overview
Table 97. IDL Biotech Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. IDL Biotech Lung Cancer Diagnostics Kit Product
Table 99. IDL Biotech Recent Developments/Updates
Table 100. LCM Genect srl Corporation Information
Table 101. LCM Genect srl Description and Business Overview
Table 102. LCM Genect srl Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. LCM Genect srl Lung Cancer Diagnostics Kit Product
Table 104. LCM Genect srl Recent Developments/Updates
Table 105. Panagene Inc. Corporation Information
Table 106. Panagene Inc. Description and Business Overview
Table 107. Panagene Inc. Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Panagene Inc. Lung Cancer Diagnostics Kit Product
Table 109. Panagene Inc. Recent Developments/Updates
Table 110. ViennaLab Diagnostics Corporation Information
Table 111. ViennaLab Diagnostics Description and Business Overview
Table 112. ViennaLab Diagnostics Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. ViennaLab Diagnostics Lung Cancer Diagnostics Kit Product
Table 114. ViennaLab Diagnostics Recent Developments/Updates
Table 115. Xian Tianlong Science and Technology Co.,Ltd Corporation Information
Table 116. Xian Tianlong Science and Technology Co.,Ltd Description and Business Overview
Table 117. Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Xian Tianlong Science and Technology Co.,Ltd Lung Cancer Diagnostics Kit Product
Table 119. Xian Tianlong Science and Technology Co.,Ltd Recent Developments/Updates
Table 120. Jiangsu Mole Bioscience Corporation Information
Table 121. Jiangsu Mole Bioscience Description and Business Overview
Table 122. Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Jiangsu Mole Bioscience Lung Cancer Diagnostics Kit Product
Table 124. Jiangsu Mole Bioscience Recent Developments/Updates
Table 125. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Corporation Information
Table 126. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Description and Business Overview
Table 127. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Lung Cancer Diagnostics Kit Product
Table 129. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments/Updates
Table 130. Gencurix Corporation Information
Table 131. Gencurix Description and Business Overview
Table 132. Gencurix Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. Gencurix Lung Cancer Diagnostics Kit Product
Table 134. Gencurix Recent Developments/Updates
Table 135. HTG Molecular Corporation Information
Table 136. HTG Molecular Description and Business Overview
Table 137. HTG Molecular Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 138. HTG Molecular Lung Cancer Diagnostics Kit Product
Table 139. HTG Molecular Recent Developments/Updates
Table 140. Beijing ACCB Biotech Ltd. Corporation Information
Table 141. Beijing ACCB Biotech Ltd. Description and Business Overview
Table 142. Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 143. Beijing ACCB Biotech Ltd. Lung Cancer Diagnostics Kit Product
Table 144. Beijing ACCB Biotech Ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Lung Cancer Diagnostics Kit Distributors List
Table 148. Lung Cancer Diagnostics Kit Customers List
Table 149. Lung Cancer Diagnostics Kit Market Trends
Table 150. Lung Cancer Diagnostics Kit Market Drivers
Table 151. Lung Cancer Diagnostics Kit Market Challenges
Table 152. Lung Cancer Diagnostics Kit Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lung Cancer Diagnostics Kit
Figure 2. Global Lung Cancer Diagnostics Kit Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Lung Cancer Diagnostics Kit Market Share by Type in 2023 & 2030
Figure 4. Non-Small Cell Lung Cancer Product Picture
Figure 5. Small Cell Lung Cancer Product Picture
Figure 6. Global Lung Cancer Diagnostics Kit Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Lung Cancer Diagnostics Kit Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Cancer Research Centers
Figure 10. Global Lung Cancer Diagnostics Kit Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Lung Cancer Diagnostics Kit Market Size (2019-2030) & (US$ Million)
Figure 12. Global Lung Cancer Diagnostics Kit Sales (2019-2030) & (Tons)
Figure 13. Global Lung Cancer Diagnostics Kit Average Price (US$/Ton) & (2019-2030)
Figure 14. Lung Cancer Diagnostics Kit Report Years Considered
Figure 15. Lung Cancer Diagnostics Kit Sales Share by Manufacturers in 2023
Figure 16. Global Lung Cancer Diagnostics Kit Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Lung Cancer Diagnostics Kit Players: Market Share by Revenue in 2023
Figure 18. Lung Cancer Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Lung Cancer Diagnostics Kit Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Lung Cancer Diagnostics Kit Sales Market Share by Country (2019-2030)
Figure 21. North America Lung Cancer Diagnostics Kit Revenue Market Share by Country (2019-2030)
Figure 22. United States Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Lung Cancer Diagnostics Kit Sales Market Share by Country (2019-2030)
Figure 25. Europe Lung Cancer Diagnostics Kit Revenue Market Share by Country (2019-2030)
Figure 26. Germany Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Lung Cancer Diagnostics Kit Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Lung Cancer Diagnostics Kit Revenue Market Share by Region (2019-2030)
Figure 33. China Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Lung Cancer Diagnostics Kit Sales Market Share by Country (2019-2030)
Figure 41. Latin America Lung Cancer Diagnostics Kit Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Lung Cancer Diagnostics Kit Sales Market Share by Country (2019-2030)
Figure 46. Middle East & Africa Lung Cancer Diagnostics Kit Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Lung Cancer Diagnostics Kit Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Lung Cancer Diagnostics Kit by Type (2019-2030)
Figure 51. Global Revenue Market Share of Lung Cancer Diagnostics Kit by Type (2019-2030)
Figure 52. Global Lung Cancer Diagnostics Kit Price (US$/Ton) by Type (2019-2030)
Figure 53. Global Sales Market Share of Lung Cancer Diagnostics Kit by Application (2019-2030)
Figure 54. Global Revenue Market Share of Lung Cancer Diagnostics Kit by Application (2019-2030)
Figure 55. Global Lung Cancer Diagnostics Kit Price (US$/Ton) by Application (2019-2030)
Figure 56. Lung Cancer Diagnostics Kit Value Chain
Figure 57. Lung Cancer Diagnostics Kit Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
